Validating a breast cancer score in Spanish women. The MCC-Spain study

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Dierssen Sotos, Trinidad
• dc.contributor.author Bustamante Pineda, Mariona
• dc.contributor.author Vinyals, G.C.
• dc.contributor.author Kogevinas, Manolis
• dc.contributor.author Llorca, Javier
• dc.date.accessioned 2019-02-01T09:13:04Z
• dc.date.available 2019-02-01T09:13:04Z
• dc.date.issued 2018
• dc.description.abstract A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
• dc.format.mimetype application/pdf
• dc.identifier.citation Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Fernández-Navarro P, Altzibar JM, González-Donquiles C. et al. Validating a breast cancer score in Spanish women. The MCC-Spain study. Sci Rep. 2018 Feb 14;8(1):3036. DOI: 10.1038/s41598-018-20832-0
• dc.identifier.doi http://dx.doi.org/10.1038/s41598-018-20832-0
• dc.identifier.issn 2045-2322
• dc.identifier.uri http://hdl.handle.net/10230/36471
• dc.language.iso eng
• dc.publisher Nature Research
• dc.relation.ispartof Scientific Reports. 2018 Feb 14;8(1):3036
• dc.rights This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.other Mama -- Càncer
• dc.title Validating a breast cancer score in Spanish women. The MCC-Spain study
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion